A rendering of the Lithoplasty balloon catheter, screenshot--Courtesy of Shockwave Medical Medical device makers are scrambling to develop and sell advanced angioplasty balloons to treat peripheral ...

Shockwave Medical, which markets a system that delivers ultrasound shockwaves to treat peripheral artery disease, has notched a CE mark, this time for the treatment of coronary artery disease. The ...

Shockwave Medical, Inc. (“Shockwave”) owns U.S. Patent No. 8,956,371 (“the ’371 patent”). This patent is directed to the treatment of atherosclerosis through intravascular lithotripsy (“IVL”). The ...

Shockwave owns US Patent No. 8,956,371 (the “’371 patent”), which is directed to the treatment of atherosclerosis through intravascular lithotripsy. The claimed device is for a “typical over-the-wire ...

Bay Area device startup Shockwave Medical just raised $40 million to build out its balloon catheters to be used in peripheral, coronary and aortic valve surgeries. It uses the same basic technology ...

FREMONT, Calif.--(BUSINESS WIRE)--Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced the company’s key activities at the annual Transcatheter ...

Johnson & Johnson today announced the global launch of the Shockwave C2 Aero coronary intravascular lithotripsy (IVL) catheter.

Johnson & Johnson (NYSE: JNJ) announced today the global launch of its Shockwave C2 Aero Coronary IVL Catheter designed for ...

FREMONT, Calif.--(BUSINESS WIRE)--Shockwave Medical, a pioneer in the treatment of advanced peripheral and coronary vascular disease, today announced CE Mark regulatory approval for the company’s ...